BioCardia, Inc. Net Income Loss

• BioCardia, Inc. showed a decrease of -3.5% in Net Income Loss from 2024 to 2025.
• This data is from BioCardia, Inc.'s annual report (Form 10-K), filed with the SEC on March 24, 2026.
• XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 16 years of available data (2010 to 2025), BioCardia, Inc.'s Net Income Loss has grown by 28.5%.
• Historical annual values: Fiscal year 2025: -$8.23 million | Fiscal year 2024: -$7.95 million | Fiscal year 2023: -$11.57 million | Fiscal year 2022: -$11.91 million | Fiscal year 2021: -$12.62 million | Fiscal year 2020: -$15.00 million | Fiscal year 2019: -$14.71 million | Fiscal year 2018: -$13.99 million | Fiscal year 2017: -$12.31 million | Fiscal year 2016: -$10.31 million | Fiscal year 2015: -$6.70 million | Fiscal year 2014: $234.0 thousand | Fiscal year 2013: $19.0 thousand | Fiscal year 2012: $305.0 thousand | Fiscal year 2011: $9.66 million | Fiscal year 2010: -$11.51 million.
• Data sourced from SEC EDGAR public filings as of June 21, 2026.

Last verified: June 21, 2026